AG
CRL icon

Algert Global’s Charles River Laboratories CRL Stock Holding History

Algert Global’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Sell
13,180
-1,540
-10% -$274K 0.04% 721
2026
Q1 		$2.54M Sell
14,720
-18,146
-55% -$3.36M 0.04% 652
2025
Q4 		$6.56M Sell
32,866
-80,004
-71% -$14.5M 0.1% 339
2025
Q3 		$17.7M Buy
112,870
+39,586
+54% +$6.29M 0.3% 63
2025
Q2 		$11.1M Buy
73,284
+50,974
+228% +$6.8M 0.23% 101
2025
Q1 		$3.36M Buy
22,310
+21,150
+1,823% +$3.55M 0.08% 417
2024
Q4 		$214K Buy
+1,160
New +$223K 0.01% 1063
2022
Q2 		– Sell
-4,641
Closed -$1.32M – 1229
2022
Q1 		$1.32M Buy
+4,641
New +$1.43M 0.09% 396
2021
Q3 		– Sell
-954
Closed -$353K – 1024
2021
Q2 		$353K Sell
954
-458
-32% -$153K 0.12% 245
2021
Q1 		$409K Buy
+1,412
New +$392K 0.13% 243

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Algert Global's CRL Position: Q2 2026 in Review

Algert Global reduced its Charles River Laboratories (CRL) stake by 10% in Q2 2026, selling an estimated $274K and leaving 13,180 shares worth $2.99M. The position accounts for 0.04% of the portfolio, ranked #721.

Algert Global first reported a position in CRL in Q1 2021 and has held it in 10 quarters since. The position peaked at $17.7M in Q3 2025. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Algert Global held 13,180 shares of Charles River Laboratories worth $2.99M as of Q2 2026.
  • Algert Global sold 1,540 Charles River Laboratories shares in Q2 2026, an estimated $274K.
  • Charles River Laboratories made up 0.04% of Algert Global's portfolio in Q2 2026, its #721 holding.
  • Algert Global first reported a position in Charles River Laboratories in Q1 2021 and has held it in 10 quarters since.
  • Algert Global's Charles River Laboratories position peaked at $17.7M in Q3 2025.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.